参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/08/28 | 1,674 | 1,694 | 1,669 | 1,674 | +17 | +1% | 1,306,100 |
2017/08/25 | 1,674 | 1,680 | 1,656 | 1,657 | -5 | -0.3% | 873,600 |
2017/08/24 | 1,674 | 1,679 | 1,659 | 1,662 | -16 | -1% | 635,900 |
2017/08/23 | 1,700 | 1,702 | 1,671 | 1,678 | -10 | -0.6% | 897,700 |
2017/08/22 | 1,681 | 1,695 | 1,673 | 1,688 | +9 | +0.5% | 816,500 |
2017/08/21 | 1,663 | 1,680 | 1,654 | 1,679 | +19 | +1.1% | 1,123,500 |
2017/08/18 | 1,659 | 1,668 | 1,647 | 1,660 | -30 | -1.8% | 1,188,700 |
2017/08/17 | 1,698 | 1,705 | 1,685 | 1,690 | -20 | -1.2% | 865,000 |
2017/08/16 | 1,698 | 1,712 | 1,679 | 1,710 | +19 | +1.1% | 900,000 |
2017/08/15 | 1,669 | 1,703 | 1,654 | 1,691 | +11 | +0.7% | 1,593,500 |
2017/08/14 | 1,683 | 1,687 | 1,671 | 1,680 | -26 | -1.5% | 1,156,000 |
2017/08/10 | 1,700 | 1,714 | 1,693 | 1,706 | -2 | -0.1% | 798,500 |
2017/08/09 | 1,694 | 1,711 | 1,687 | 1,708 | +6 | +0.4% | 1,168,400 |
2017/08/08 | 1,705 | 1,719 | 1,699 | 1,702 | +3 | +0.2% | 1,238,900 |
2017/08/07 | 1,711 | 1,714 | 1,698 | 1,699 | -11 | -0.6% | 831,200 |
2017/08/04 | 1,700 | 1,715 | 1,699 | 1,710 | +8 | +0.5% | 1,006,600 |
2017/08/03 | 1,692 | 1,716 | 1,681 | 1,702 | +6 | +0.4% | 1,578,300 |
2017/08/02 | 1,679 | 1,713 | 1,663 | 1,696 | +108 | +6.8% | 3,917,700 |
2017/08/01 | 1,556 | 1,592 | 1,555 | 1,588 | +31 | +2% | 1,008,800 |
2017/07/31 | 1,556 | 1,572 | 1,555 | 1,557 | +1 | +0.1% | 778,400 |
2017/07/28 | 1,544 | 1,558 | 1,538 | 1,556 | +1 | +0.1% | 1,031,100 |
2017/07/27 | 1,565 | 1,571 | 1,555 | 1,555 | -12 | -0.8% | 1,232,300 |
2017/07/26 | 1,576 | 1,589 | 1,552 | 1,567 | -20 | -1.3% | 1,360,100 |
2017/07/25 | 1,587 | 1,592 | 1,572 | 1,587 | ±0 | ±0% | 1,776,700 |
2017/07/24 | 1,603 | 1,603 | 1,583 | 1,587 | -33 | -2% | 952,700 |
2017/07/21 | 1,625 | 1,626 | 1,604 | 1,620 | -12 | -0.7% | 689,100 |
2017/07/20 | 1,598 | 1,643 | 1,597 | 1,632 | +35 | +2.2% | 1,254,900 |
2017/07/19 | 1,567 | 1,597 | 1,565 | 1,597 | +28 | +1.8% | 1,062,600 |
2017/07/18 | 1,585 | 1,595 | 1,557 | 1,569 | -12 | -0.8% | 1,258,100 |
2017/07/14 | 1,579 | 1,586 | 1,573 | 1,581 | -13 | -0.8% | 890,200 |
2017/07/13 | 1,590 | 1,598 | 1,585 | 1,594 | +9 | +0.6% | 889,600 |
2017/07/12 | 1,566 | 1,593 | 1,562 | 1,585 | +17 | +1.1% | 1,262,700 |
2017/07/11 | 1,565 | 1,570 | 1,555 | 1,568 | +5 | +0.3% | 846,800 |
2017/07/10 | 1,550 | 1,564 | 1,540 | 1,563 | +19 | +1.2% | 1,572,600 |
2017/07/07 | 1,549 | 1,566 | 1,531 | 1,544 | -17 | -1.1% | 2,679,400 |
2017/07/06 | 1,537 | 1,565 | 1,536 | 1,561 | +35 | +2.3% | 2,176,800 |
2017/07/05 | 1,519 | 1,526 | 1,504 | 1,526 | +8 | +0.5% | 1,034,900 |
2017/07/04 | 1,535 | 1,542 | 1,510 | 1,518 | -10 | -0.7% | 1,042,100 |
2017/07/03 | 1,525 | 1,536 | 1,515 | 1,528 | +4 | +0.3% | 1,004,700 |
2017/06/30 | 1,500 | 1,527 | 1,498 | 1,524 | +17 | +1.1% | 2,052,800 |
2017/06/29 | 1,517 | 1,531 | 1,506 | 1,507 | -13 | -0.9% | 1,280,800 |
2017/06/28 | 1,526 | 1,531 | 1,515 | 1,520 | -8 | -0.5% | 925,300 |
2017/06/27 | 1,536 | 1,549 | 1,525 | 1,528 | -4 | -0.3% | 1,096,900 |
2017/06/26 | 1,517 | 1,534 | 1,511 | 1,532 | +15 | +1% | 723,700 |
2017/06/23 | 1,526 | 1,531 | 1,511 | 1,517 | -9 | -0.6% | 1,208,100 |
2017/06/22 | 1,516 | 1,529 | 1,511 | 1,526 | +29 | +1.9% | 2,094,600 |
2017/06/21 | 1,487 | 1,498 | 1,471 | 1,497 | +5 | +0.3% | 1,609,800 |
2017/06/20 | 1,500 | 1,502 | 1,489 | 1,492 | -1 | -0.1% | 910,800 |
2017/06/19 | 1,479 | 1,503 | 1,478 | 1,493 | +10 | +0.7% | 1,108,500 |
2017/06/16 | 1,505 | 1,516 | 1,477 | 1,483 | -18 | -1.2% | 2,126,200 |
1951~
2000
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ロート | 253,900円 | +8.4% | +6.4% | 1.65% | 18.21倍 | 2.21倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム